Skip to main content

Actelion Pharmaceuticals U.S., Inc.

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming Actelion Pharmaceuticals U.S., Inc. are currently shown as ongoing. The 1 record below is a historical recall record.

Public Health Trace has 1 recall naming Actelion Pharmaceuticals U.S., Inc. as the recalling firm, republished from official FDA and USDA sources.

Recall history - 1 terminated record

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20131
Download CSV

FDA Recall TerminatedTerminated: July 23, 2013Historical recordClass III

Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.

by Actelion Pharmaceuticals U.S., Inc.

Reason
Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.
Published
February 13, 2013
Distribution
CA & VA

View recall →

Showing 1–1 of 1 results

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Actelion Pharmaceuticals U.S., Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.